December 23, 2024 UVA Health’s Dr. Neeral Shah Earns Virginia Outstanding Faculty Award

UVA Health’s Neeral Shah, MD, is one of 12 recipients of the State Council of Higher Education for Virginia’s 2025…

December 18, 2024 Rett Syndrome Discovery Could Lead to Better Treatment

New discoveries about Rett syndrome could open the door to better treatments for the devastating, life-shortening developmental disorder.

December 17, 2024 UVA Health Children’s, Sentara Martha Jefferson Hospital Opening Pediatric Neurodevelopmental and Behavioral Health Care Clinic

UVA Health Children’s and Sentara Martha Jefferson Hospital have partnered to open a new clinic to expand access to behavioral…

December 16, 2024 Newsweek Ranks UVA Health University Medical Center Virginia’s No. 1 Hospital

Newsweek’s Best-in-State Hospitals 2025 list ranks UVA Health University Medical Center as Virginia’s No. 1 hospital.

December 3, 2024 Trial Identifies Better Treatment for Grade 2 Gliomas

Adding the chemotherapy pill temozolomide to radiation treatment significantly improves survival for adults with brain tumors known as grade 2 gliomas, a clinical trial led by a top UVA Health cancer expert has found.

November 27, 2024 UVA Health Salutes Team Members With Donations to 5 Nonprofits

To honor and appreciate its more than 18,000 team members as the holiday season begins, UVA Health is donating $7,500 each to five Virginia nonprofits in Charlottesville, Culpeper and Northern Virginia.

November 25, 2024 UVA Cancer Center Partnering to Expand Lung Cancer Screenings in Rural Virginia, West Virginia

UVA Cancer Center, Appalachian Community Cancer Alliance and Buchanan General Hospital (BGH) have teamed up to make getting screened for lung cancer easier for residents of rural Virginia and West Virginia.

November 21, 2024 Trial Tests Focused Ultrasound to Battle Melanoma

UVA's melanoma trial will evaluate the safety and effectiveness of using focused sound waves in conjunction with immunotherapy and surgery.

November 20, 2024 Weight-Loss Drug Tirzepatide Reduces Heart Failure Deaths

Tirzepatide, from pharmaceutical company Eli Lilly and Co., was tested in the SUMMIT clinical trial at 146 sites in the United States and abroad.

November 19, 2024 Technique Improves Coronary Artery Disease Diagnosis

A new technology which allows doctors to quantify blood flow in the heart can improve their ability to diagnose deadly coronary artery disease, an international study led by School of Medicine investigators has found.